Strategic Merger Leverage the January 2022 merger with Probo Medical to position REMETRONIX as a combined force in medical imaging equipment services, expanding cross-sell opportunities for both installation, deinstallation, and maintenance of CT, MR, PET/CT, X-ray, and proton therapy systems.

Geographic Footprint Target expansion and account penetration across the US and UK offices (Florida, Georgia, California, London) to win service contracts and ongoing maintenance for high-tech imaging equipment in healthcare facilities and research centers.

High-Value Projects Capitalize on the current project load of 1,500 annual engagements, emphasizing disaster recovery, installation, service, and rigging for complex equipment to win multi-site service agreements and long-term maintenance contracts with OEMs and healthcare providers.

Tech & Compliance Promote ISO 9001-2008 certification and robust technical expertise to reassure customers about quality management, regulatory compliance, and reliability, enabling premium service levels and favorable renewal rates.

Mid-Market Focus Position REMETRONIX as a capable partner for mid-market imaging and radiation therapy centers seeking responsive, competitive service with scalable resources, leveraging the company’s 51-200 employee base to propose flexible SLAs and faster response times.